Research Progress On The Chemical Constituents And Pharmacological Effects Of Sinapis Semen And Prediction Analysis Of Its Quality‑Related Efficacy Substances (Q‑Marker)
Apr 15, 2026
Abstract
Sinapis Semen is a key warming, phlegm‑transforming herb in traditional Chinese medicine (TCM), traditionally used to warm the Lung, resolve cold‑phlegm, regulate qi, dissipate nodules, unblock collaterals, and relieve pain. Modern studies indicate that Sinapis Semen contains multiple classes of constituents-primarily glucosinolates, sinapine‑type alkaloids, flavonoids, and volatile oils. Among these, sinapine thiocyanate has been listed in the Pharmacopoeia of the People's Republic of China (2020 edition) as a quality‑control marker for Sinapis Semen. However, current quality evaluation remains relatively single‑indicator and may not comprehensively reflect its overall efficacy‑substance basis; deeper research is still needed.
This paper systematically summarizes progress in the chemical constituent and pharmacological studies of Sinapis Semen, and-based on the "three elements" of TCM efficacy substances (clear material basis, quantitative dose–effect relationship, and defined mechanisms) and the "five principles" of quality markers (Q‑Markers)-performs a multidimensional prediction analysis. The analysis suggests that sinalbin, sinigrin, sinapine, sinapine thiocyanate, and allyl isothiocyanate (AITC), among others, may constitute a core efficacy‑related marker cluster for more scientific and comprehensive quality control of Sinapis Semen.
Keywords
Sinapis Semen; efficacy substances; quality markers; sinalbin; sinigrin; sinapine; sinapine thiocyanate; allyl isothiocyanate (AITC)
A new herb, Cistanche, supplement for prostate and kidney health
Marketing‑and‑R&D Positioning Note (for prostate‑health developers)
This article's experimental and literature evidence is centered on Sinapis Semen (mustard seed). For companies developing botanical products in men's urological health (e.g., BPH/LUTS support programs), the practical value lies in:
a multi‑component evidence map (constituents → mechanisms → models), and
a Q‑Marker‑driven quality strategy that can be adapted to other herbs (including Cistanche) without misattributing evidence.
A dedicated section at the end of this English version provides a Cistanche‑oriented development roadmap using the same Q‑Marker logic (QC specs, analytical methods, claim architecture, and evidence planning).
Supportive Service Of Wecistanche-For more details about cooperation
Email:wallence.suen@wecistanche.com
Introduction
Sinapis Semen is the dried mature seed of Sinapis alba L. (commonly called white mustard seed) or Brassica juncea (L.) Czern. et Coss. (commonly called brown/yellow mustard seed), both in the family Brassicaceae. The former is traditionally referred to as "Bai Jie Zi" (white mustard seed) and the latter as "Huang Jie Zi" (yellow/brown mustard seed). It is widely distributed in China, with major production in Henan and Anhui provinces.
In TCM theory, Sinapis Semen is pungent and warm in nature, enters the Lung meridian, and is traditionally used to warm the Lung, resolve phlegm, regulate qi, dissipate nodules, unblock collaterals, and relieve pain. It is commonly used for conditions such as cold‑phlegm cough and wheezing, chest and hypochondriac distension and pain, phlegm obstruction of channels and collaterals, numbness and pain of joints/limbs, and yin‑type sores and toxic swellings; it also has a "medicine‑food homology" attribute. 111
Modern research suggests that the main constituents of Sinapis Semen include glucosinolates (GS) (e.g., sinalbin), alkaloids (e.g., sinapine), organic acids (e.g., erucic acid–related components), fixed oils and volatile oils, and shows pharmacological activities including anti‑inflammatory and analgesic effects, antitussive/expectorant/anti‑asthmatic effects, and inhibition of prostate hyperplasia, with broad potential applications. 222
This review systematically summarizes chemical constituents and pharmacological effects of Sinapis Semen. Based on a multidimensional association framework-"chemical constituents–biosynthetic pathways–traditional functions–modern pharmacology"-and integrating the "three elements" of efficacy substances and the "five principles" of Q‑Markers, we predict potential quality‑related efficacy substances to support construction of a more scientific and comprehensive quality standard system for Sinapis Semen.
Herb Extract Quality Assessment
1. Chemical Constituents
With the development of analytical technologies-especially chromatography–mass spectrometry (LC–MS), NMR, and high‑resolution MS-research on the chemical profile of Sinapis Semen has progressed substantially. Studies indicate that Sinapis Semen contains structurally diverse and bioactive constituents, mainly including glucosinolates, alkaloids, fatty acids, volatile oils, flavonoids, phenolic derivatives, amino acids and derivatives, and sugars/glycosides. Additional components such as sterols, terpenes, nucleotides, and other lipophilic constituents have also been reported. These findings provide an important foundation for elucidating the efficacy‑substance basis of Sinapis Semen.
1.1 Glucosinolates (GS)
Glucosinolates (GS), also referred to as thioglucosides, are characteristic secondary metabolites in Sinapis Semen and represent a key material basis for its pharmacological activities. 333 Structurally, a glucosinolate consists of three hallmark units: a sulfated oxime group, a β‑D‑thioglucose moiety, and a variable side chain (R group). The sulfated oxime and β‑D‑thioglucose together form the core scaffold. Based on the chemical features of the R group, GS are typically classified into aliphatic, aromatic, and indole glucosinolates.
To date, a total of 13 GS constituents (1–13) have been identified in Sinapis Semen (details are summarized in the original work's Table 1). In white mustard seed and yellow/brown mustard seed, the major GS are sinalbin and sinigrin, respectively. Under catalysis by myrosinase, these compounds undergo degradation to generate irritant isothiocyanates.
Developer note (QC): For a standardized botanical ingredient program, GS (e.g., sinalbin/sinigrin) are strong candidates for a marker cluster because they are (i) characteristic to Brassicaceae, (ii) quantifiable by LC methods, and (iii) directly connected to downstream bioactive breakdown products (isothiocyanates).
1.2 Sinapine‑type Alkaloids
Sinapine‑type alkaloids are the dominant alkaloid constituents in Sinapis Semen. They are quaternary ammonium alkaloids and are widely present in Brassicaceae plants. 999 Five such alkaloids (14–18) have been reported in Sinapis Semen, among which sinapine thiocyanate is considered the principal in‑plant form. 333 The summarized list is provided in the original paper's Table 1.
Regulatory/marketing note: In outward‑facing materials (especially in the U.S.), it is usually safer to describe these as "standardization markers for identity and consistency" rather than implying direct disease treatment.
1.3 Fatty Acids
Sinapis Semen contains a rich diversity of fatty acids, which are long‑chain carboxylic acids (basic building blocks of lipids such as fats, oils, and phospholipids). GC–MS has played a major role in identifying these constituents. Multiple studies using GC–MS identified varying numbers of fatty acids in white mustard seed extracts, and supercritical CO2_22 extraction generally produced higher absolute contents than petroleum ether–ultrasound extraction, with broadly similar profiles dominated by unsaturated fatty acids such as erucic acid, oleic acid, linoleic acid, linolenic acid, and eicosenoic acid. The fatty acids (19–54) are summarized in the original paper's Table 1.
1.4 Volatile Oils
Volatile oils are considered one of the core active component sets in Sinapis Semen. Key components include isothiocyanates (e.g., allyl isothiocyanate, AITC), GS hydrolysis products, aldehydes/ketones, alcohols, and terpenes. Isothiocyanates are produced via hydrolysis of GS (e.g., sinigrin and sinalbin) under the action of myrosinase. Due to their characteristic R–N=C=S functionality, they have attracted extensive research interest and are associated with a distinctive pungent odor and potential biological activities.
Notably, the volatile‑oil composition differs substantially between varieties (white vs. yellow/brown mustard seed), and this difference can directly influence clinical and application value. Volatile‑oil constituents (55–162) are detailed in the original work's Table 1.
1.5 Flavonoids
Flavonoids are one of the major classes of secondary metabolites in Sinapis Semen and exhibit notable chemical diversity and bioactivity. To date, 10 flavonoid compounds (163–172) have been identified from Sinapis Semen, as summarized in the original work (Table 1).
DSHEA‑aligned R&D note: In supplement positioning, flavonoid fractions are often framed as supporting antioxidant capacity or healthy inflammatory response, and are typically handled in QC via "total flavonoids" (colorimetric) plus one or two anchor compounds when available.
1.6 Phenolic Derivatives
Phenolic derivatives constitute an important group of bioactive constituents in Sinapis Semen, including phenolic acids, phenolic alcohols, and phenolic ketones. A total of 26 phenolic derivative compounds (173–198) have been identified and summarized in the original work's Table 2.
1.7 Amino Acids and Their Derivatives
Multiple amino acids are present in Sinapis Semen. In white mustard seed, researchers have identified 12 amino acids (199–210) and 12 amino‑acid derivatives (211–222), as summarized in the original work's Table 2.
1.8 Sugars and Glycosides
Using UHPLC–MS/MS, Torrijos et al. identified 8 glycosides (223–230) from Sinapis Semen. Additional work identified sugars such as maltotriose, maltose, and α‑lactose (231–233). One glycoside, daucosterol (234), was also reported.
Regarding polysaccharides, studies indicate that white mustard seed polysaccharides are composed of multiple neutral monosaccharides-predominantly glucose, followed by galactose, mannose, rhamnose, arabinose, and xylose-and also contain a substantial proportion of uronic acids. In addition, xyloglucan components isolated from cotyledons of dormant white mustard seeds were described as having a typical amyloid‑like architecture with a (1→4)(1\rightarrow4)(1→4)-β‑D‑glucose backbone and xylose‑rich side chains at C‑6, with notable differences in side‑chain structures between fractions. An arabinan from mustard embryos and broader surveys of mustard seed polysaccharides suggested that pectic polysaccharides are dominant.
1.9 Other Compounds
Beyond the categories above, Sinapis Semen also contains compounds such as sterols, terpenes, nucleotides, vitamins, and other lipophilic constituents (excluding fatty acids), summarized as compounds 235–263 in the original work (Table 3).
2. Pharmacological Effects
Sinapis Semen is pungent and warm in TCM, primarily entering the Lung meridian, and is traditionally used to regulate qi, transform phlegm, disperse nodules, unblock collaterals, and relieve pain. Modern pharmacology suggests that its glucosinolates, sinapine‑type alkaloids, volatile oils, and other constituents may act through multi‑target and multi‑pathway mechanisms. Reported activity areas include respiratory support (antitussive/expectorant/anti‑asthmatic effects), modulation of inflammatory signaling (e.g., NF‑κB‑related pathways), preclinical effects in prostate‑hyperplasia models, transdermal permeation enhancement, and potential anti‑tumor, antioxidant, and immunomodulatory activities.
DSHEA positioning note: The findings summarized below largely derive from in vitro and animal studies. In U.S. dietary supplement contexts, these data can support R&D rationale and structure/function positioning (e.g., "supports respiratory comfort," "supports a healthy inflammatory response," "supports prostate health"), but do not by themselves establish disease treatment claims in humans.
2.1 Antitussive, Expectorant, and Anti‑asthmatic (Respiratory Support)
Sinapis Semen has been widely used clinically for respiratory‑related conditions. Its antitussive, expectorant, and anti‑asthmatic effects represent modern pharmacological correlates of the traditional function "warming the Lung and transforming phlegm," and have been supported by multiple in vivo and in vitro experiments.
Wang Hui et al. reported that sinapine is one of the efficacy substances associated with antitussive and anti‑asthmatic activity. In their work, oral administration (ig) of sinapine at 14.8 and 74.0 mg/kg, as well as aerosol/spray administration of sinapine at 91.9, 459.5, and 919.0 mg/L, significantly prolonged the latency of acetylcholine‑induced asthma onset in guinea pigs. The proposed functional basis included relaxation of airway smooth muscle and increased lung and tracheal capacity, contributing to anti‑asthmatic effects.
Yu Zhengjiang isolated p‑hydroxybenzyl cyanide from white mustard seed and confirmed its antitussive activity. Feng Baomin et al. compared pre‑ and post‑processing (stir‑frying) white mustard seed using an ammonia‑water cough model (latency and cough frequency). The processed product demonstrated enhanced antitussive activity; notably, after 10 minutes of stir‑frying, the content of p‑hydroxybenzyl cyanide increased to 7.5 times that of the pre‑processed material, further supporting this compound as a key antitussive material basis for white mustard seed.
Zhang Xuemei et al. evaluated respiratory‑related activity of different solvent extracts. Results suggested: the ethanol extract had a clear antitussive effect; the water extract showed favorable expectorant activity; and the petroleum ether extract significantly antagonized 4% acetylcholine chloride‑induced asthma in guinea pigs.
Table 1 (reconstructed from text; replacing Figure 1). Respiratory‑related pharmacology of Sinapis Semen
| Efficacy direction | Material basis / candidate actives | Model & route (as described) | Main endpoints (as described) | Mechanistic notes (as described) | DSHEA‑appropriate structure/function framing |
|---|---|---|---|---|---|
| Anti‑asthmatic / bronchodilation support | Sinapine | Guinea pig acetylcholine‑induced asthma; ig and aerosol/spray | Prolonged asthma latency; increased lung/tracheal capacity | Airway smooth muscle relaxation | "Helps support healthy airway tone and breathing comfort" |
| Antitussive support | p‑Hydroxybenzyl cyanide | Ammonia water cough model; processing comparison | Processed product stronger; compound content increased markedly after stir‑frying | Processing‑dependent efficacy substance | "Helps support cough comfort" (avoid disease claims) |
| Antitussive / expectorant / anti‑asthmatic (fraction‑dependent) | Ethanol vs. water vs. petroleum ether extracts | Multiple animal models | Ethanol: antitussive; water: expectorant; petroleum ether: anti‑asthmatic | Activity varies by fraction chemistry | "Supports fraction‑guided formulation design and QC" |
2.2 Anti‑inflammatory and Analgesic (Support for Healthy Inflammatory Response & Pain‑Related Comfort)
The traditional function "unblocking collaterals and relieving pain" is reflected in modern research as anti‑inflammatory and analgesic activity. Mechanistically, reported effects are closely related to modulation of inflammatory signaling pathways and inhibition of inflammatory mediator release.
Gao Yuan et al. reported that transdermal administration of white mustard seed produced a significant therapeutic effect in a rat model of rheumatoid arthritis. Compared with the model group, the treatment group showed reduced serum levels of IL‑1β and TNF‑α, and reduced relative expression of TLR4 and NF‑κB proteins in ankle synovial tissue, suggesting potential involvement of inhibition of the TLR4/NF‑κB inflammatory axis.
Wan Junmei et al. evaluated anti‑inflammatory and analgesic effects of different white mustard seed fractions using xylene‑induced mouse ear swelling, acetic acid‑induced writhing, and the hot‑plate test. Both the water fraction and ethyl acetate fraction showed anti‑inflammatory and analgesic activity, with differences among fractions; the water fraction was identified as the primary effective fraction.
Li Xiaoli et al. found that an ethanol extract of white mustard seed at 300 and 600 mg/kg showed strong anti‑inflammatory and analgesic effects: it significantly inhibited increased capillary permeability and ear swelling in mice; it also prolonged pain response latency and reduced writhing frequency, with stronger effects at higher doses.
Xian et al. reported that both white and yellow/brown mustard seed at 250 mg/kg significantly reduced ear swelling in mouse acute inflammation models induced by TPA and arachidonic acid (AA), as well as in a chronic inflammation model induced by carbon monoxide (CO), and significantly inhibited myeloperoxidase activity in ear tissue. The mechanism was proposed to involve suppression of mRNA expression of inflammatory mediators such as TNF‑α, IL‑6, and IL‑1β.
Table 2 (reconstructed from text; replacing Figure 2). Anti‑inflammatory/analgesic evidence map for Sinapis Semen
| Preparation / fraction | Model (as described) | Key endpoints reported | Pathway / mediator notes | DSHEA‑aligned product interpretation |
|---|---|---|---|---|
| White mustard seed, transdermal administration | Rat rheumatoid arthritis model | ↓ IL‑1β, ↓ TNF‑α; ↓ TLR4 and NF‑κB expression in synovium | Possible TLR4/NF‑κB axis involvement | "Supports a healthy inflammatory response and joint comfort" |
| Water fraction; ethyl acetate fraction | Mouse ear swelling, writhing, hot‑plate tests | Anti‑inflammatory and analgesic effects; water fraction primary | Fraction‑dependent | "Helps maintain healthy inflammatory balance" |
| Ethanol extract (300/600 mg/kg) | Mouse capillary permeability, ear swelling; pain assays | Reduced inflammation indices; increased pain latency; dose‑responsive | - | "Supports pain‑related comfort associated with normal inflammation" |
| White & yellow/brown mustard seeds (250 mg/kg) | TPA/AA acute inflammation; CO chronic inflammation (mouse ear) | Reduced ear swelling; ↓ MPO activity | ↓ TNF‑α/IL‑6/IL‑1β mRNA | "Provides preclinical support for inflammation‑modulating potential" |
2.3 Preclinical Effects in Models of Prostate Hyperplasia (Prostate‑Health Support Rationale)
Studies summarized in the article suggest that white mustard seed and certain active constituents may act through multiple targets and pathways in preclinical models relevant to prostate hyperplasia.
Liu Ming et al. studied different extracts in castrated mice with testosterone propionate‑induced prostate hyperplasia. The ethanol extract significantly inhibited testosterone propionate‑induced prostate hyperplasia and significantly reduced serum acid phosphatase activity, whereas the water‑decoction extract did not show this effect.
Wu Guoxin et al. reported that components including β‑sitosterol (8 and 16 mg/kg), sinalbin (8 and 16 mg/kg), and unsaturated fatty acids may act synergistically-reducing capillary permeability, inhibiting fibrous tissue proliferation, lowering serum acid phosphatase activity, and showing anti‑androgen‑related actions-thereby inhibiting prostate hyperplasia in this preclinical context. Further experiments indicated that sinalbin and β‑sitosterol each inhibited prostate hyperplasia in a dose‑related manner; additionally, their anti‑inflammatory emphases differed: sinalbin exhibited anti‑granuloma proliferation at higher doses, while β‑sitosterol reduced capillary permeability across the tested dose range.
Chen Miyu reported that components including sinalbin, sinapine, β‑sitosterol, and volatile oil from white mustard seed could reduce expression of VEGF and bFGF in prostate‑hyperplasia tissue in experimental mice; in addition, sinalbin and sinapine were reported to inhibit androgen receptor expression in the same context.
Lin Yanni reported that sinapine, sinalbin, and β‑sitosterol at 16 and 32 mg/kg, and volatile oil at 8 and 16 mg/kg, showed significant therapeutic and preventive effects in mice with testosterone propionate‑induced experimental prostate hyperplasia, and improved histopathological features. The mechanism was proposed to relate to promotion of apoptosis in prostate cells, leading to reduced prostate volume and weight.
DSHEA wording guidance: In a U.S. supplement dossier, the most compliant take‑home statement is that these findings provide a preclinical rationale for "prostate health support," rather than implying treatment of benign prostatic hyperplasia.
Table 3 (reconstructed from text; replacing Figure 3). Prostate‑hyperplasia model findings and development takeaways
| Preparation / compound(s) | Model (as described) | Doses / exposure | Main findings (as described) | Biomarker / mechanism notes | DSHEA‑aligned framing for a product dossier |
|---|---|---|---|---|---|
| White mustard seed ethanol extract | Castrated mice + testosterone propionate‑induced prostate hyperplasia | - | Inhibited hyperplasia; ↓ serum acid phosphatase | - | "Preclinical support for maintaining healthy prostate tissue responses" |
| β‑Sitosterol; Sinalbin; unsaturated fatty acids (synergy proposed) | Prostate hyperplasia model (mouse) | β‑Sitosterol 8/16 mg/kg; Sinalbin 8/16 mg/kg | Dose‑related inhibition; reduced permeability; anti‑androgen‑related actions | Lowered serum acid phosphatase; fraction synergy | "Supports prostate health; informs marker selection (β‑sitosterol + GS anchors)" |
| Sinalbin; Sinapine; β‑Sitosterol; volatile oil | Experimental mouse prostate hyperplasia tissue | - | ↓ VEGF, ↓ bFGF; sinalbin/sinapine ↓ androgen receptor expression | Growth factor & AR expression | "Mechanism‑guided hypothesis for prostate‑health support (preclinical)" |
| Sinapine / Sinalbin / β‑Sitosterol; volatile oil | Testosterone propionate‑induced prostate hyperplasia in mice | Alkaloid/GS/sterol 16/32 mg/kg; volatile oil 8/16 mg/kg | Therapeutic & preventive effects; improved pathology | Proposed apoptosis promotion; ↓ prostate size/weight | "Supports R&D rationale; not a human disease |
2. Pharmacological Effects (continued)
2.4 Transdermal Permeation Enhancement (Topical Delivery Enablement)
Raw white mustard seed is strongly dispersing and pungent; after stir‑frying, skin irritation is reduced, which is consistent with its common use in clinical acupoint‑application therapies. Studies summarized in the article suggest that white mustard seed-particularly its volatile oil fraction-may enhance transdermal delivery of co‑administered actives and contribute to synergistic effects in topical/acupoint contexts.
Wang Dixin et al. reported mutual permeation‑enhancing effects between white mustard seed and Asarum (Xi Xin), and suggested that the herb‑pair compatibility and acupoint effects may synergistically promote permeation, though mechanisms require further clarification.
Gao Yuan et al. compared, in a rabbit rheumatoid‑arthritis model, formulations with vs. without white mustard seed and administration at acupoints vs. non‑acupoints, assessing effects on skin permeation of tetrahydropalmatine (Yanhu Suo Yi Su). Acupoint administration outperformed non‑acupoint delivery, and the permeation‑enhancing effect showed some relationship with the dosage of white mustard seed.
Ruan Shifa et al. performed in vitro transdermal studies using excised rat skin as a barrier and found that white mustard seed volatile oil could effectively promote transdermal permeation/absorption of actives in "winter‑disease treated in summer" formulations (including tetrahydropalmatine and certain Asarum constituents), providing both therapeutic contribution and permeation enhancement.
Yang Dan et al. examined effects of different white mustard seed components on in vitro transdermal permeation of berberine hydrochloride and found that the volatile oil promoted permeation, with an optimal mass fraction reported as 0.5%.
Table 4 (reconstructed from text; replacing Figure 4). Transdermal enhancement evidence and formulation implications
| Component / pairing | Study design (as described) | Key finding | Practical formulation takeaway (DSHEA‑ready) |
|---|---|---|---|
| White mustard seed + Asarum herb pair | In vitro permeation; acupoint compatibility discussed | Mutual permeation enhancement suggested; mechanism unclear | Use as a rationale for topical "delivery‑support" design; requires safety/irritation controls |
| White mustard seed in "winter‑disease treated in summer" topical formula | Rabbit RA model; acupoint vs non‑acupoint; with vs without white mustard seed | Acupoint > non‑acupoint; effect correlated with mustard dose | Supports acupoint‑product R&D narrative; keep claims to "supports topical delivery/comfort" |
| Volatile oil fraction | Ex vivo rat skin permeation | Enhanced permeation of co‑actives | Volatile oil can be positioned as a processing‑sensitive functional fraction and QC marker |
| Volatile oil fraction (0.5% best reported) | In vitro berberine permeation | Enhanced permeation; optimal concentration noted | Guides dose‑range screening for topical prototypes (with irritation testing) |
2.5 Anti‑tumor (Preclinical Findings)
The article summarizes studies reporting that Sinapis Semen may inhibit certain tumor cell lines or tumor growth in experimental settings; reported contributors include sinapine thiocyanate, sinapine sulfate/bisulfate forms, and volatile oil components. These findings remain preclinical.
Wu Shengxi et al. reported that white mustard seed volatile oil inhibited growth of tumor cells in H22 tumor‑bearing mice in a dose‑related manner. The mechanism was proposed to involve down‑regulation of Bcl‑2 and up‑regulation of Bax, thereby promoting apoptosis.
Chen Tengxiang et al. reported that sinapine thiocyanate inhibited proliferation, migration, and invasion of human hepatocellular carcinoma SMMC‑7721 cells, decreased protein expression of PTGS1, PTGS2, Bcl‑2, MMP2, and MMP9, and increased Bax expression.
Su Yushan reported that sinapine thiocyanate inhibited proliferation, epithelial–mesenchymal transition, and metastasis‑related behaviors of human skin squamous cell carcinoma SCL‑1 cells in a dose‑related manner, potentially via inhibition of EGFR/PI3K/Akt pathway activation.
Jeyaraj et al. reported cytotoxicity of yellow/brown mustard seed toward MCF‑7 and A549 cells in a dose‑related manner in their experimental system. Jin Xuan et al. reported that white mustard seed extract inhibited proliferation, migration, and invasion of cervical cancer cells, potentially related to regulation of certain gene/miRNA expression.
DSHEA caution: For U.S. supplement materials, these anti‑tumor findings are generally not suitable for outward claims; they can be retained as internal R&D background, but consumer‑facing messaging should avoid cancer‑related implications.
2.6 Antioxidant
Studies summarized in the article indicate that both yellow/brown mustard seed and white mustard seed exhibit antioxidant capacity in vitro and in vivo, potentially via free‑radical scavenging, enhancement of endogenous antioxidant enzyme systems, and modulation of related signaling pathways.
Jeyaraj et al. reported that yellow/brown mustard seed showed strong DPPH radical scavenging (reported up to 89.42% in their system). Zhang et al. reported that both types of mustard seed showed antioxidant and oxidative‑damage protective effects in vitro, with yellow/brown mustard seed performing better.
Sun Yanwei reported that an aqueous extract of yellow/brown mustard seed did not show DPPH scavenging under the tested conditions but could scavenge hydroxyl radicals and exhibited ferric‑reducing capacity. In an H2_22O2_22‑induced oxidative injury model using HepG2 cells, the aqueous extract and hydrolysis products improved cell viability, increased antioxidant enzyme activities (including SOD, CAT, and GSH‑Px), and reduced LDH leakage, ROS, and MDA levels.
Zhao Qiang et al. reported that polysaccharides from yellow/brown mustard seed showed antioxidant activity under experimental conditions, with DPPH and hydroxyl radical scavenging positively correlated with concentration.
Shi Ying et al. reported that white mustard seed demonstrated antioxidant capacity in vivo and in vitro. A water extract at 10 mg/mL scavenged hydroxyl radicals and DPPH radicals, mitigated oxidative and heat stress, and reduced lipofuscin and ROS levels; the mechanism was proposed to involve regulation of insulin‑signaling‑related gene expression.
Table 5 (reconstructed from text; replacing Figure 5). Antioxidant evidence map and QC relevance
| Material / fraction | Model (as described) | Endpoints (as described) | Notes | DSHEA‑aligned outward framing |
|---|---|---|---|---|
| Yellow/brown mustard seed | In vitro DPPH | High DPPH scavenging reported | System‑dependent | "Provides antioxidant support" |
| Yellow & white mustard seed polyphenols | In vitro oxidative protection | Antioxidant and protective effects; yellow/brown better | Extraction optimization noted in cited work | "Supports antioxidant capacity" |
| Yellow/brown mustard aqueous extract & hydrolysates | HepG2 H2_22O2_22 oxidative injury model | ↑ viability; ↑ SOD/CAT/GSH‑Px; ↓ LDH/ROS/MDA | DPPH negative but hydroxyl scavenging positive reported | Use multi‑assay antioxidant panel; avoid single‑assay conclusions |
| Yellow/brown mustard polysaccharides | In vitro radical scavenging | DPPH & hydroxyl scavenging correlated with concentration | Class‑level marker | "Supports cellular antioxidant defenses" (structure/function) |
| White mustard water extract | In vitro scavenging; in vivo stress models (as described) | Radical scavenging; ↓ ROS/lipofuscin; stress mitigation | Proposed insulin‑signaling gene involvement | Supports "oxidative stress management" narrative |
Sinapis Semen: Evidence‑Mapped, Q‑Marker‑Driven Ingredient Concept (Internal/BD Summary)
What it is
Sinapis Semen (mustard seed; Bai Jie Zi / Huang Jie Zi) is a traditional botanical with a well‑characterized chemistry framework including glucosinolates (GS), sinapine‑type alkaloids, volatile oils (isothiocyanates), polyphenols, and polysaccharides. Current pharmacopoeial QC emphasizes sinapine thiocyanate, but the literature supports a broader, multi‑marker approach.
Why it matters for U.S. supplement development
A multi‑component/Q‑Marker strategy can improve:
Identity & authenticity (species/processing differentiation)
Batch consistency (multi‑analyte standardization vs single marker)
Mechanism‑aligned positioning (respiratory comfort, healthy inflammatory response, antioxidant support, and prostate‑health support rationale based on preclinical models)
DSHEA‑appropriate structure/function positioning (examples)
Respiratory comfort: supports healthy airway tone and cough comfort (preclinical support).
Healthy inflammatory response: supports joint and tissue comfort associated with normal inflammation (preclinical support).
Antioxidant capacity: supports antioxidant defenses (multi‑assay preferred).
Prostate health: supports healthy prostate function and urinary comfort (based on preclinical models; no disease claims).
Proposed QC marker cluster (conceptual)
GS anchors: sinalbin (white mustard) and sinigrin (brown/yellow mustard)
Alkaloid anchor: sinapine thiocyanate (pharmacopoeial alignment)
Volatile anchor: allyl isothiocyanate (AITC) and related isothiocyanates (processing‑sensitive)
Supportive classes: polyphenols / polysaccharides (class‑level markers for consistency)
Next pages will specify: (1) analytics and stability considerations, (2) processing impact markers, and (3) a prostate‑health product developer checklist.
2.7 Immunomodulatory Activity (Support for Immune Function)
The article summarizes evidence that Sinapis Semen and certain fractions/components may modulate immune responses in experimental systems, including effects on immune‑organ indices, immune cell activity, and inflammatory mediator profiles. Reported contributors include polysaccharides and other extract fractions, though the exact material basis may vary by species, processing, and extraction method.
From a product‑development perspective, these findings support using Sinapis Semen fractions as immune‑support research candidates, while recognizing that clinical substantiation and careful safety evaluation are needed before strong consumer messaging.
DSHEA framing: "Supports immune function" and "helps maintain immune balance" are typical structure/function directions; avoid implying prevention or treatment of infection or immune disease.
2.8 Antibacterial / Antimicrobial (Preclinical)
The article notes that Sinapis Semen has reported antimicrobial activity, which is commonly attributed-at least in part-to volatile constituents such as isothiocyanates. Reported studies include inhibitory activity against certain microorganisms under experimental conditions.
DSHEA caution: In the U.S., consumer‑facing supplement claims should avoid "antibacterial/antiviral" implications (often interpreted as disease claims). This evidence is best kept as internal R&D background or translated into safer language such as "supports a healthy microbial balance," if appropriately substantiated.
2.9 Anti‑fibrotic / Anti‑adhesion (Preclinical)
The article summarizes research indicating that white mustard seed may reduce adhesion and fibrosis in certain experimental settings. These findings are discussed as part of the broader "unblocking collaterals" pharmacological correlation and may involve modulation of inflammatory mediators and tissue remodeling pathways.
For development, this domain is best treated as mechanism background supporting "healthy tissue response" narratives rather than outward claims.
2.10 Other Activities
Additional activities summarized in the article include (but are not limited to) effects related to metabolic regulation, oxidative‑stress mitigation beyond classic antioxidant assays, and other multi‑system effects reported in cell/animal studies. As with other sections, translation into U.S. supplement positioning should remain within structure/function boundaries and emphasize that much of the evidence is preclinical.
3. Quality Marker (Q‑Marker) Prediction and Analysis (Translation + DSHEA‑oriented interpretation)
The article proposes that Q‑Markers for Sinapis Semen should reflect a combination of:
(1) measurability and controllability, (2) specificity/traceability to the herb, (3) relationship to traditional efficacy, (4) modern pharmacological relevance, and (5) **consistency across processing and dosage forms.
Based on literature and network‑pharmacology–style reasoning, the article emphasizes glucosinolates and their degradation products, sinapine‑type alkaloids, and selected lipophilic constituents as candidate Q‑Markers.
Table 6 (reconstructed; replacing Figure 6). Candidate Q‑Marker decision table for Sinapis Semen (developer‑ready)
| Candidate marker | Chemical class | Species/processing relevance | Evidence linkage (from article) | QC practicality | Suggested role in a U.S. supplement spec |
|---|---|---|---|---|---|
| Sinapine thiocyanate | Alkaloid derivative | Widely used as a pharmacopeial assay marker | Linked to respiratory, inflammation, and other activities in the article | High (HPLC/UPLC) | Primary assay marker (aligns with existing standards) |
| Sinalbin | Glucosinolate (white mustard) | Differentiates white mustard; processing‑sensitive | Linked to prostate‑hyperplasia model findings and other effects | Medium–High (LC) | Identity + supporting assay marker (GS cluster) |
| Sinigrin | Glucosinolate (brown/yellow mustard) | Differentiates brown/yellow mustard | Linked to volatile breakdown products; broad bioactivity rationale | Medium–High (LC) | Identity/fingerprint anchor for species selection |
| Isothiocyanates (e.g., AITC) | Volatile degradation products of GS | Strongly processing‑ and storage‑sensitive | Linked to topical permeation enhancement and antimicrobial rationale | Medium (GC) | Processing/stability marker; fingerprint component |
| β‑Sitosterol | Sterol | Lipophilic fraction; supportive across batches | Linked to prostate‑hyperplasia model findings | Medium (LC/GC) | Supporting marker for prostate‑health R&D positioning |
| Total polyphenols / flavonoids | Phenolics | Influenced by extraction | Linked to antioxidant narrative | High (class assays) | Class‑level consistency marker (secondary) |
| Polysaccharides (total + composition) | Carbohydrates | Extraction‑dependent | Linked to antioxidant/immune narratives | Medium (class + profiling) | Class‑level marker (secondary; for specific SKUs) |
Implementation note: A practical DSHEA‑oriented approach is a "1 primary + 2–4 secondary markers" spec: one mandatory assay (often sinapine thiocyanate), plus a glucosinolate anchor (sinalbin or sinigrin depending on species), plus one volatile/stability marker and one supportive lipophilic marker.
4. Conclusion
Sinapis Semen (mustard seed; Sinapis Semen) is a traditional botanical characterized by a pungent, warming profile and a long history of topical and internal use consistent with the functions of regulating qi, transforming phlegm, dispersing nodules, and relieving discomfort. Modern studies summarized in this article suggest that its pharmacological activities are multi‑component and multi‑pathway in nature, with candidate material bases including glucosinolates (e.g., sinalbin/sinigrin) and their degradation products (isothiocyanates/related volatiles), sinapine‑type alkaloids (notably sinapine thiocyanate), selected lipophilic constituents (e.g., β‑sitosterol and unsaturated fatty acids), as well as polyphenols and polysaccharides.
Across preclinical models and in vitro systems, reported effect directions include respiratory‑related support (antitussive/expectorant/anti‑asthmatic correlates), modulation of inflammatory signaling (e.g., TLR4/NF‑κB‑related findings), antioxidant capacity, and topical permeation enhancement in external application contexts. In addition, studies in experimental models relevant to prostate hyperplasia indicate that certain extracts and constituents may influence androgen‑related signaling, tissue growth factor expression, and apoptosis‑related pathways, providing a preclinical rationale for "prostate health support" research. However, these findings are predominantly non‑clinical and should be interpreted as mechanistic and exploratory evidence rather than proof of therapeutic efficacy in humans.
For quality control and standardization, a Q‑Marker strategy that integrates measurable, traceable, and efficacy‑relevant constituents is recommended. In practice, aligning with pharmacopeial conventions while adopting a marker "cluster" approach (e.g., a primary assay marker such as sinapine thiocyanate supplemented by glucosinolate and volatile/stability markers) can better reflect the herb's multi‑component nature, improve batch consistency, and support formulation and process optimization (including processing‑dependent chemical transformations).
Overall, Sinapis Semen shows meaningful potential as a botanical ingredient for structure/function product concepts such as respiratory comfort, maintenance of a healthy inflammatory response, antioxidant support, and prostate‑health support-provided that future work strengthens the evidence base through robust analytical standardization, safety evaluation (especially for topical irritation and volatile‑component sensitivity), and well‑designed human studies that appropriately match the intended use scenario and dosage form.
